CIRB Studies
Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.
To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.
| Study Number | Lead Group | Study Title | CIRB | Study Status |
|---|---|---|---|---|
| NWU20-01-03 | CLO-Northwestern University | Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease (NAFLD): RELIEF-NAFLD | Cancer Prevention and Control CIRB | Available to Open |
| NWU2014-04-01 | CLO-Northwestern University | Statin Therapy to Reduce the Risk of Recurrent Pancreatitis | Cancer Prevention and Control CIRB | Completed |
| NWU20-02-01 | CLO-Northwestern University | Surgical Window of Opportunity Study of Megestrol Acetate Compared with Megestrol Acetate and Metformin for Endometrial Intraepithelial Neoplasia | Cancer Prevention and Control CIRB | Available to Open |
| NWU2015-06-01 | CLO-Northwestern University | Evaluating Intermittent Dosing of Aspirin for Colorectal Cancer Chemoprevention | Cancer Prevention and Control CIRB | Available to Open |
| NWU2017-09-01 | CLO-Northwestern University | Phase I trial of endoxifen gel versus placebo gel in women undergoing breast surgery | Cancer Prevention and Control CIRB | Available to Open |
| NWU2015-06-04 | CLO-Northwestern University | Phase IIB trial of neoadjuvant oral tamoxifen versus transdermal 4-hydroxytamoxifen in women with DCIS of the breast | Cancer Prevention and Control CIRB | Available to Open |
| NWU20-02-02 | CLO-Northwestern University | A Randomized and Placebo-Controlled Phase II Trial Targeting Dominant-Negative Missense Mutant P53 By Atorvastatin for Reducing the Risk of Longstanding Ulcerative Colitis-Associated Cancer | Cancer Prevention and Control CIRB | Available to Open |
| NWU2015-06-03 | CLO-Northwestern University | Statin Therapy to Reduce Disease Progression from Liver Cirrhosis to Cancer | Cancer Prevention and Control CIRB | Available to Open |
| NWU20-04-01 | CLO-Northwestern University | Metformin for Chemoprevention of Lung Cancer in High-Risk Overweight or Obese Individuals | Cancer Prevention and Control CIRB | Available to Open |
| INT21-05-01 | CLO-Northwestern University | Phase IIB Clinical Trial of the Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury) Vaccine (TRI-AD5) and IL-15 Superagonist N-803 in Lynch Syndrome | Cancer Prevention and Control CIRB | Available to Open |